Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Fujifilm's Scale Eye Endoscope Gets FDA Nod to Measure Colonic Lesions - Medical Product Outsourcing
OEM News

Fujifilm’s Scale Eye Endoscope Gets FDA Nod to Measure Colonic Lesions

Scale Eye consists of a laser-equipped colonoscope and endoscopy support software.

Fujifilm Healthcare Americas has been granted U.S. Food and Drug Administration (FDA) 510(k) clearance for Scale Eye, a new endoscopic imaging technology and part of the company’s growing Eluxeo endoscopic imaging system.
 
Scale Eye consists of a laser-equipped colonoscope and endoscopy support software and displays a linear or circular virtual measurement over the area of interest on the endoscopy monitor. Using it, endoscopists can estimate the size of colorectal lesions in vivo without needing visual estimations, consumable tools, or further surgical instruments.
 
The company said compared to a biopsy forceps methods, Scale Eye allows more accurate, objective colon polyp size measurement, an important factor for clinical management of neoplasms.
 
The company also shared data regarding Scale Eye’s use versus current methods in use. Its accuracy rate was 98.2% compared to 89% measuring with forceps, and measurement time was 2.8 seconds compared to eight seconds. Fujifilm also noted visual measurement overestimated polyp size in 57.3% of cases.
 
The company said it plans to commercially launch Scale Eye in 2024 following limited market evaluation.
 
“During colonoscopy, it is important to correctly measure the size of the polyps because it can directly impact the patient’s care pathway,” said Tai Fujita, VP, Endoscopy Division, Fujifilm Healthcare Americas Corporation. “Early clinical results of SCALE EYE are impressive, and we’re proud that Fujifilm’s new, innovative in vivo scaling capability is demonstrating success in improving both the speed and accuracy of polyp measurement.”

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters